GH therapy improves short-term emotional and social life quality for short stature children
Children with short stature show marked improvements in their emotional and social quality of life during their first year of treatment with growth hormone, study findings suggest.
Early oestrogen initiation in Turner syndrome boosts adulthood bone health
A probable underlying genetic cause may be found for the majority of children with severe familial short stature, with mutations in growth plate genes accounting for most of these, research shows.
Growth plate gene mutations may underlie many severe familial short stature cases
A probable underlying genetic cause may be found for the majority of children with severe familial short stature, with mutations in growth plate genes accounting for most of these, research shows.
GH therapy improves short-term emotional and social life quality for short stature children
Children with short stature show marked improvements in their emotional and social quality of life during their first year of treatment with growth hormone, study findings suggest.
Reduced GH dose after catch-up growth maintains height gains
Most children continue on a normal growth trajectory if their recombinant human growth hormone dose is reduced by half after they have achieved catch-up growth, shows a randomised trial.
Latest GeNeSIS data confirm rhGH efficacy and long-term safety profile
Two reports from the GeNeSIS observational study reveal the latest growth data and confirm that the safety profile of recombinant human growth hormone “remains favourable”.
SYNERGY trial supports rhGH therapy for idiopathic short stature
The SYNERGY trial investigators report significant improvements in height velocity in South Korean children with idiopathic short stature treated with daily recombinant human growth hormone.
Real-time GH adherence data confirm impact on growth outcomes
Real-time data on treatment adherence show its importance for good growth outcomes in patients taking recombinant human growth hormone.
Metabolic outcomes may need close monitoring during GH therapy in girls
Growth hormone therapy has a greater impact on the metabolic outcomes of girls than boys, research suggests.
Low stimulated peak GH linked to hyperuricaemia in obese children
Obese children with reduced peak stimulated growth hormone are likely to have hyperuricaemia, along with markers of increased cardiovascular risk, research shows.
